Song, Honglin
Li, Xi
Lu, Jiang
Song, Junjie
Wang, Teng
Gao, Min
Zhang, Xingyi
Ma, Min
Shi, Yi
Fang, Jiayu
Fu, Hongchen
Wang, Huadan
Duo, Lin
Tang, Mingjing
Pang, Linhong
Funding for this research was provided by:
building a joint laboratory for important chronic and epidemic diseases in South and Southeast Asia (202103AF140002, 202103AF140002, 202103AF140002, 202103AF140002)
Yunnan Provincial Clinical Research Center for Cardiovascular Diseases-New Technology Research and Development Project for Diagnosis and Treatment of Major Cardiovascular Diseases (202102AA310002, 202102AA310002, 202102AA310002)
Provincial Innovation Team Project of Heart Failure Diagnosis and Treatment in Fuwai Yunnan Cardiovascular Hospital (202005AE160020, 202005AE160020)
Key Research and Development Program from Yunnan Province Science and Technology Department (202103AF140002)
Article History
Received: 9 May 2023
Accepted: 18 May 2023
First Online: 7 June 2023
Declarations
:
: The ethics committee at the Fuwai Yunnan Cardiovascular Hospital approved this project (Number 2018-01). Informed consent was obtained from all subjects and/or their legal guardian(s). The study protocol adheres to the ethical guidelines of the 1975 Declaration of Helsinki.Each CHD case was classified and coded according to the International Classification of Diseases version 10 and belonged to the code range from Q20 to Q28. The classification showed that there were more than 15 types of defects in our study area.
: Not applicable.
: The authors declared no relevant conflict of interest.